What breaks when AI agents can write into clinical systems without output governance?

The control failure is that security teams end up governing access paths while missing the behaviour that matters most: what the agent writes back. When output can change silently inside an approved workflow, DLP, EHR audit logs, and egress tools may all stay green while clinical decisions are corrupted. That is a governance failure in the agent identity and write authority, not just a monitoring gap.

Why This Matters for Security Teams

Clinical systems are high-trust environments because a single write action can affect diagnosis, medication, triage, billing, or follow-up care. When an AI agent can write into those systems, the core question is no longer whether the agent is authenticated, but whether its outputs are governed before they become patient-facing or workflow-driving records. That distinction is central to the NIST AI Risk Management Framework and to current agentic AI guidance.

The practical failure mode is subtle. A tool may have valid access, approved session scopes, and normal SIEM activity, yet still insert inaccurate summaries, wrong coding suggestions, or misleading task updates. Once those writes land inside an electronic health record, downstream users may treat them as trusted clinical context. That makes output governance a safety control, not just a content-quality control. It also means identity assurance alone is insufficient if the agent has broad write authority.

Security and clinical governance teams often underestimate how quickly a harmless-looking assistant becomes a source of record contamination, especially when human review is optional or buried in workflow friction. In practice, many security teams encounter agent output failures only after a clinician has already acted on a corrupted entry, rather than through intentional pre-write validation.

How It Works in Practice

Output governance is the set of controls that checks, constrains, and records what an AI agent is allowed to write before the write occurs. In clinical environments, that usually means separating read assistance from write authority, requiring structured output schemas, and forcing a human approval step for any action that changes patient records, orders, or care tasks. The point is not to block all automation, but to make the write path explicit and auditable.

A workable implementation usually combines policy, technical guardrails, and logging. The OWASP Agentic AI Top 10 is useful here because it highlights risks such as excessive agency, unsafe tool use, and weak output validation. Mapping those risks to workflow controls helps teams decide where the agent may draft text, where it may propose actions, and where it must stop.

• Limit the agent to draft-only mode for clinical notes unless a separate approval gate exists.
• Validate output against schema, vocabulary, and policy before it is committed to the system of record.
• Require provenance tags so reviewers can see which fields were AI-generated or modified.
• Log both the model output and the final committed record to support audit and incident review.
• Block direct writes to high-impact fields unless a clinician or privileged workflow owner confirms them.

For threat modelling, teams should align this work with the MITRE ATLAS adversarial AI threat matrix and the CSA MAESTRO agentic AI threat modeling framework, especially where prompt injection, tool misuse, or retrieval manipulation could influence what the agent writes back. These controls tend to break down when the AI agent is embedded inside a legacy EHR integration that treats machine-generated text as equivalent to clinician-authored content because the workflow lacks a distinct approval state.

Common Variations and Edge Cases

Tighter output controls often increase workflow friction, requiring organisations to balance patient safety against speed and clinician usability. That tradeoff is real, and current guidance suggests the safest pattern is not uniform restriction, but risk-tiered governance based on the sensitivity of the field being written.

For low-risk tasks such as draft summarisation, teams may allow broader agent output with lightweight review. For high-impact actions such as medication changes, discharge instructions, diagnostic impressions, or order entry, best practice is evolving toward deterministic checks, explicit approval, and field-level restrictions. There is no universal standard for this yet, but the direction of travel is clear: the more the output can influence care, the narrower the agent’s write authority should be.

Another edge case is partial automation inside approved workflows. A system can pass access reviews and still fail governance if it writes into the wrong namespace, updates a free-text field that downstream systems trust, or rewrites clinical context in a way that is hard to distinguish from human input. Organisations should pair output governance with broader security posture controls from the NIST Cybersecurity Framework 2.0, because confidentiality and integrity controls alone do not stop unsafe clinical action.

In practice, this breaks down most often in legacy healthcare integrations where free-text writes, weak field validation, and unclear ownership let agent output enter the record without a final accountable reviewer.

Related resources from NHI Mgmt Group

• What breaks when AI agents are given broad enterprise access without tight governance?
• What breaks when legacy systems are exposed to agents without schema governance?
• What breaks when AI agents use session-based micropayments without governance?
• What breaks when AI agents are given access without identity governance?